KYLE HOUSE GROUP

Lobbying for US PHARMACOPEIA · Pharmaceutical manufacturing

Filing 1st Quarter - Report

1st Quarter (Jan 1 - Mar 31) 2026 · Maryland · House · Senate · $20,000.00 income · posted Apr 20, 2026

Lobbying activity 2

Foreign Relations

Education and advocacy in support of global health, global medical supply chains, and quality assurance programs.

Health Issues

Education and advocacy in support of global health, global medical supply chains, and quality assurance programs.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.